An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: Results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapy
| Image |  |
|---|---|
| Description | scientific article published on 6 April 2017 |
| Author/s |
author: Einat Brill-Almon Raul Chertkoff Sari Alon Yaron Ilan |
| Publication date | April 6, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |